104
Participants
Start Date
January 31, 2014
Primary Completion Date
April 30, 2015
Study Completion Date
April 30, 2015
Calcium carbonate ( Intensive phosphate control)
Individuals randomized to this arm will be exposed to a treatment strategy that targets a P of \< 1.50 mmol/L, reflecting the recommendations of current guidelines. Titration of the calcium carbonate dose will be the core of this approach and this will be complemented by usual recommendations regarding dietary P restriction. Dietitians will be available to provide counseling with regards to any aspect of the end-stage renal disease diet, as per usual dialysis unit practice
Calcium carbonate (Liberalized phosphate control)
"Individuals in this arm will be exposed to a treatment strategy that allows P to rise above 2.00 mmol/L. This will be accomplished through structured reduction of P binders already in use (as per the algorithm detailed below). Rescue P binding will be instituted if P rises above 2.50 mmol/L. Dietitians will be available to provide counseling regarding any aspect of the end-stage renal disease diet, as per usual dialysis unit practice, but will not provide counseling on dietary P restriction unless the P rises above 2.50 mmol/L."
Foothills Medical Centre, Calgary
Capital District Health Authority, Halifax
St. Joseph's Healthcare, Hamilton
London Health Sciences Centre, London
St. Michael's Hospital, Toronto
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
Unity Health Toronto
OTHER